Cargando…

Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

BACKGROUND: Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no Japanese clinical data on an oxaliplatin dose of 130 mg/m(2). The current research involves a single-arm, prospective, phase II clinical trial to examine the efficacy and safety of oxaliplatin + S-1 with an ox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeki, Hiroshi, Emi, Yasunori, Oki, Eiji, Tokunaga, Shoji, Kakeji, Yoshihiro, Akagi, Yoshito, Baba, Hideo, Baba, Eishi, Maehara, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759242/ https://www.ncbi.nlm.nih.gov/pubmed/29310611 http://dx.doi.org/10.1186/s12885-017-3937-6

Ejemplares similares

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)
por: Satake, Hironaga, et al.
Publicado: (2016)

A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)
por: Ogata, Yutaka, et al.
Publicado: (2015)

Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial
por: Oki, Eiji, et al.
Publicado: (2020)

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)
por: Miwa, Keisuke, et al.
Publicado: (2021)

Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives
por: Maehara, Yoshihiko, et al.
Publicado: (2011)

IgG4-related disease of the ileocecal region mimicking malignancy: A case report
por: Hiyoshi, Yukiharu, et al.
Publicado: (2014)

Molecular mechanisms regulating the hormone sensitivity of breast cancer
por: Tokunaga, Eriko, et al.
Publicado: (2014)

DNA replication stress and cancer chemotherapy
por: Kitao, Hiroyuki, et al.
Publicado: (2017)

Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus
por: Nakanoko, Tomonori, et al.
Publicado: (2013)

Erratum to: Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus
por: Nakanoko, Tomonori, et al.
Publicado: (2013)

Prognostic impact of MutT homolog‐1 expression on esophageal squamous cell carcinoma
por: Akiyama, Shingo, et al.
Publicado: (2016)

Recent advances in treatment for colorectal liver metastasis
por: Oki, Eiji, et al.
Publicado: (2018)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2016)

Non-cirrhotic portal-systemic encephalopathy caused by enlargement of a splenorenal shunt after pancreaticoduodenectomy for locally advanced duodenal cancer: report of a case
por: Kasagi, Yuta, et al.
Publicado: (2013)

Progression from laparoscopic-assisted to totally laparoscopic distal gastrectomy: comparison of circular stapler (i-DST) and linear stapler (BBT) for intracorporeal anastomosis
por: Ikeda, Tetsuo, et al.
Publicado: (2012)

Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women
por: Tokunaga, Eriko, et al.
Publicado: (2016)

Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11b(high)/Gr1(high) myeloid cells
por: Iwai, Toshiki, et al.
Publicado: (2018)

Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
por: Lim, Sung Hee, et al.
Publicado: (2021)

Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
por: Ota, Mitsuhiko, et al.
Publicado: (2023)

Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancer
por: Shitara, Kohei, et al.
Publicado: (2021)

The requirement of Mettl3-promoted MyoD mRNA maintenance in proliferative myoblasts for skeletal muscle differentiation
por: Kudou, Kensuke, et al.
Publicado: (2017)

Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
por: Kim, Seung Tae, et al.
Publicado: (2016)

Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cells
por: Ikawa-Yoshida, Ayae, et al.
Publicado: (2013)

The antibodies against 5-bromo-2′-deoxyuridine specifically recognize trifluridine incorporated into DNA
por: Kitao, Hiroyuki, et al.
Publicado: (2016)

Breve historia de Cartagena 1501-1901 /
por: Lemaitre Román, Eduardo, 1914-1994
Publicado: (1983)

Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study
por: Imamura, Yu, et al.
Publicado: (2020)

Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
por: Takahashi, I., et al.
Publicado: (1994)

The early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients
por: Taketani, Kenji, et al.
Publicado: (2013)

Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer
por: Tokunaga, Eriko, et al.
Publicado: (2013)

Rad9, Rad17, TopBP1 and Claspin Play Essential Roles in Heat-Induced Activation of ATR Kinase and Heat Tolerance
por: Tuul, Munkhbold, et al.
Publicado: (2013)

A Case of Panitumumab-Responsive Metastatic Rectal Cancer Initially Refractory to Cetuximab
por: Kasagi, Yuta, et al.
Publicado: (2013)

Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability
por: Iimori, Makoto, et al.
Publicado: (2016)

Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma
por: Tsutsumi, Satoshi, et al.
Publicado: (2017)

High ubiquitin‐specific protease 44 expression induces DNA aneuploidy and provides independent prognostic information in gastric cancer
por: Nishimura, Sho, et al.
Publicado: (2017)

Anal metastasis of rectal cancer—adenocarcinoma of squamous cells: a case report and literature review
por: Sasaki, Shun, et al.
Publicado: (2017)

Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level
por: Kataoka, Yuki, et al.
Publicado: (2019)

Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
por: Kakeji, Y., et al.
Publicado: (1993)

A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)
por: Oki, E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_is05ak9bhfdnm2l68qd1nje6hv